NASDAQ:VTGN   Vistagen Therapeutics, Inc.
Hi, today we are going to talk about VistaGen Therapeutics Inc and its current landscape.

VistaGen Therapeutics Inc despite the high volatility of this penny stock it could be hiding a gold mine as the company has received Fast Track designation by the FDA for the development of the company's PH94B neuroactive nasal spray for on-demand treatment of social anxiety disorder. The clinical-stage biopharmaceutical company has been developing this new generation of medicines for central nervous system diseases and disorders that don't have their needs by the currently products on the market, with this FDA designation PH94B that it's preparing to enter on its phase 3 development, has the potential of being next VistaGen gem, since could meet the need of 15 million adults that in the U.S (6.8% of the population), suffers of social anxiety disorder*, a context that made VistaGen Therapeutics worth to follow closely.


Thank you for reading and leave your comments if you like.
To have access to our exclusive contents, join the Traders Heaven today! Link Below.


*ADAA - Anxiety and Depression Association of America

Disclaimer: All content of Golden Dragon has only educational and informational purposes, and never should be used or take it as financial advice.

Haftungsausschluss

Die Informationen und Veröffentlichungen sind nicht als Finanz-, Anlage-, Handels- oder andere Arten von Ratschlägen oder Empfehlungen gedacht, die von TradingView bereitgestellt oder gebilligt werden, und stellen diese nicht dar. Lesen Sie mehr in den Nutzungsbedingungen.